That’s not how I see it.
It’s stated that $24.40 is arrived at using a sum of the parts risk-adjusted DCF valuation. Thus the current $24.40 valuation includes both trofinetide and NNZ-2591.
How much value is attributed to each of the assets is unclear.
But, whatever E&P's estimated current value of NNZ-2591 is, you would need to deduct that from the $45.90 figure.
Also, the $21.50 value attributable to NNZ-2591 if all indications are successful, suggests a total potential value for NNZ-2591 of $2.8 bn, not $3.6 bn.
Neuren Media and Analyst Coverage, page-752
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.50 |
Change
0.190(0.98%) |
Mkt cap ! $2.490B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.98 | $19.38 | $7.285M | 370.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 7318 | $19.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.52 | 593 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.55 |
Change
0.190 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| $19.41 | $19.97 | $19.39 | 83274 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| NEU (ASX) Chart |